Valeant To Hold Conference Call For Investors To Provide Business Update on Tuesday, November 10, 2015 at 8:00 AM ET

Valeant Pharmaceuticals International, Inc.

announced that the Company will provide a business update for investors on a conference call to be held Tuesday, November 10, 2015 at 8:00 a.m. ET. J. Michael Pearson, Chairman and Chief Executive Officer, together with Robert Rosiello, Chief Financial Officer, Dr. Ari Kellen, Company Group Chairman, Deb Jorn, Company Group Chairman and Tanya Carro, Corporate Controller, will conduct the call. The conference call on November 10 will consist of an overview of current plans and priorities, including the transition plan from Philidor, and an update on the Company's operations.  Immediately thereafter, there will be a question and answer segment for investors and analysts. Valeant intends to host an Investor Day and update its annual and quarterly financial guidance prior to the end of 2015. Conference Call Information The Company will host a conference call at 8:00 a.m. ET (5:00 a.m. PT), November 10, 2015 to provide a business update. The dial-in number to participate on this call is (877) 876-8393 confirmation code 78262163. International callers should dial (973) 200-3961, confirmation code 78262163. A replay will be available approximately two hours following the conclusion of the conference call